InvestorsHub Logo
Followers 55
Posts 13535
Boards Moderated 0
Alias Born 10/12/2006

Re: goombajhny post# 2495

Monday, 04/17/2017 1:11:22 PM

Monday, April 17, 2017 1:11:22 PM

Post# of 2795
Aegis Capital Reiterates Buy Rating and $3 PT on Ocera Therapeutics (OCRX); 'OCR-002 Shows Preclinical Potential for NAFLD'

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.